Information
62 Yonggu-daero 2325beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea
+82 2-3463-7707
-
-
Overview
- Summary
- Sooil Development is a manufacturer of insulin pumps, infusion sets, and accessories for diabetes analysis, management, and treatment. The company pioneered the commercialization of insulin pumps globally, establishing a new history in diabetes care. It is an innovative technology company that is transforming the paradigm of diabetes management through the development of AI-based Automated Insulin Delivery (AID) systems. The company focuses on providing advanced medical solutions to improve the quality of life for people with diabetes.Sooil Development is a manufacturer of insulin pumps, infusion sets, and accessories for diabetes analysis, management, and treatment. The company pioneered the commercialization of insulin pumps globally, establishing a new history in diabetes care. It is an innovative technology company that is transforming the paradigm of diabetes management through the development of AI-based Automated Insulin Delivery (AID) systems. The company focuses on providing advanced medical solutions to improve the quality of life for people with diabetes.
- Key Products/Technologies
- Insulin Pumps: The company offers models such as Diabecare DANA-i, DANA Diabecare IIS, DANA Diabecare R, and DANA Diabecare RS. The DANA-i model features remote control via smartphone apps (Android/iOS), Secure BLE 5.0 communication, a 300-unit insulin capacity, IP68 waterproof rating, and a lightweight 86g design. The DANA R model boasts an ultralight 63g design, IPX8 waterproof rating, 300-unit capacity, PC data download, and remote control capabilities. The basal rate is adjustable from 0.04 unit/hr in 0.01 or 0.1 unit/hr increments, while bolus can be injected in 0.05, 0.1, 0.5, or 1.0 unit increments.Insulin Pumps: The company offers models such as Diabecare DANA-i, DANA Diabecare IIS, DANA Diabecare R, and DANA Diabecare RS. The DANA-i model features remote control via smartphone apps (Android/iOS), Secure BLE 5.0 communication, a 300-unit insulin capacity, IP68 waterproof rating, and a lightweight 86g design. The DANA R model boasts an ultralight 63g design, IPX8 waterproof rating, 300-unit capacity, PC data download, and remote control capabilities. The basal rate is adjustable from 0.04 unit/hr in 0.01 or 0.1 unit/hr increments, while bolus can be injected in 0.05, 0.1, 0.5, or 1.0 unit increments.
- Automated Insulin Delivery (AID) System: The company is dedicated to developing a complete artificial pancreas system that integrates Continuous Glucose Monitors (CGM) with Artificial Intelligence (AI) algorithms. Through collaboration with Diabeloop (France), it is pursuing US FDA and European CE certifications for the DBLG1 AID solution linked with the Dana-i insulin pump. This system predicts blood glucose changes and automatically adjusts insulin delivery to prevent hypoglycemia and maintain normal blood sugar levels.Automated Insulin Delivery (AID) System: The company is dedicated to developing a complete artificial pancreas system that integrates Continuous Glucose Monitors (CGM) with Artificial Intelligence (AI) algorithms. Through collaboration with Diabeloop (France), it is pursuing US FDA and European CE certifications for the DBLG1 AID solution linked with the Dana-i insulin pump. This system predicts blood glucose changes and automatically adjusts insulin delivery to prevent hypoglycemia and maintain normal blood sugar levels.
- Infusion Sets and Accessories: A diverse range of infusion sets and related accessories is provided, including Soft Release O, Soft Release ST, Easy Release, Easy Release II, and Superline-ST.Infusion Sets and Accessories: A diverse range of infusion sets and related accessories is provided, including Soft Release O, Soft Release ST, Easy Release, Easy Release II, and Superline-ST.
- Mobile App (AnyDANA): The AnyDANA app (AnyDana-i, AnyDana-A, AnyDANA Plus) enables real-time monitoring and control of insulin dosage, meal intake, exercise, and insulin delivery patterns via smartphones. The AnyDANA Plus app specifically incorporates Predictive Low Glucose Suspend (PLGS) technology, enhancing user safety and convenience in diabetes management.Mobile App (AnyDANA): The AnyDANA app (AnyDana-i, AnyDana-A, AnyDANA Plus) enables real-time monitoring and control of insulin dosage, meal intake, exercise, and insulin delivery patterns via smartphones. The AnyDANA Plus app specifically incorporates Predictive Low Glucose Suspend (PLGS) technology, enhancing user safety and convenience in diabetes management.
- Core Advantages
- World's First Commercialization of Insulin Pump and Over 47 Years of Technology: The company pioneered the development of portable insulin pumps in 1979 and successfully commercialized them in 1980, securing a leading position in diabetes treatment. It possesses over 47 years of continuous innovation and refinement in insulin pump technology.World's First Commercialization of Insulin Pump and Over 47 Years of Technology: The company pioneered the development of portable insulin pumps in 1979 and successfully commercialized them in 1980, securing a leading position in diabetes treatment. It possesses over 47 years of continuous innovation and refinement in insulin pump technology.
- Global Market Leadership and Extensive Export Network: The company has obtained quality certifications from over 60 countries, including US FDA and European CE, demonstrating its globally recognized technology and quality. It exports insulin pumps to 66 countries worldwide, including Germany, France, the UK, Israel, and China, serving as a vanguard for K-medical device exports.Global Market Leadership and Extensive Export Network: The company has obtained quality certifications from over 60 countries, including US FDA and European CE, demonstrating its globally recognized technology and quality. It exports insulin pumps to 66 countries worldwide, including Germany, France, the UK, Israel, and China, serving as a vanguard for K-medical device exports.
- Advanced AI-Based Automated Insulin Delivery System Development Capability: Through collaboration with French company Diabeloop, the company has developed a next-generation Automated Insulin Delivery (AID) system that combines Continuous Glucose Monitors (CGM) with Artificial Intelligence (AI) algorithms. This innovative technology marks the dawn of the artificial pancreas era, offering a new paradigm in diabetes management.Advanced AI-Based Automated Insulin Delivery System Development Capability: Through collaboration with French company Diabeloop, the company has developed a next-generation Automated Insulin Delivery (AID) system that combines Continuous Glucose Monitors (CGM) with Artificial Intelligence (AI) algorithms. This innovative technology marks the dawn of the artificial pancreas era, offering a new paradigm in diabetes management.
- Strong Research and Development and Industry-Academia Collaboration System: The company is committed to insulin pump technology development through close cooperation with medical, clinical, and engineering experts from leading Korean universities such as Seoul National University and Konkuk University. It established a new R&D facility in Seoul in 1999, laying the foundation for continuous technological innovation.Strong Research and Development and Industry-Academia Collaboration System: The company is committed to insulin pump technology development through close cooperation with medical, clinical, and engineering experts from leading Korean universities such as Seoul National University and Konkuk University. It established a new R&D facility in Seoul in 1999, laying the foundation for continuous technological innovation.
- User-Centric Product Design and Enhanced Safety: The company provides products that maximize patient convenience with features like smartphone app (AnyDANA) remote control, lightweight design, and waterproof capabilities. Notably, it has implemented Predictive Low Glucose Suspend (PLGS) technology, significantly enhancing the safety of its diabetes management solutions.User-Centric Product Design and Enhanced Safety: The company provides products that maximize patient convenience with features like smartphone app (AnyDANA) remote control, lightweight design, and waterproof capabilities. Notably, it has implemented Predictive Low Glucose Suspend (PLGS) technology, significantly enhancing the safety of its diabetes management solutions.
- Number 1 Market Share in Korea and Government Recognition: The company holds a dominant number one market share in the domestic insulin pump market, establishing a strong local presence. It has been recognized as a 'Global Hidden Champion' by the Small and Medium Business Administration and has received awards such as the 'Minister of Health and Welfare Award' and the 'Export Tower' award, acknowledging its technology and growth potential.Number 1 Market Share in Korea and Government Recognition: The company holds a dominant number one market share in the domestic insulin pump market, establishing a strong local presence. It has been recognized as a 'Global Hidden Champion' by the Small and Medium Business Administration and has received awards such as the 'Minister of Health and Welfare Award' and the 'Export Tower' award, acknowledging its technology and growth potential.
- Target Industries
- Diabetes analysis, management, and treatment industryDiabetes analysis, management, and treatment industry
- Medical device manufacturing industryMedical device manufacturing industry
- Smart healthcare solutions industrySmart healthcare solutions industry
- Major Markets
- Morocco (Exelle Medic)Morocco (Exelle Medic)
- China (North China: Beijing Tagene Medical Co., Ltd., South China: Shenzhen DANA Technology Co Ltd.), IsraelChina (North China: Beijing Tagene Medical Co., Ltd., South China: Shenzhen DANA Technology Co Ltd.), Israel
- Germany (Mediq), France (Medlife SAS), United Kingdom (Advanced Therapeutics (UK) Ltd.), Netherlands, Luxembourg, Belgium, Poland (Aero-Medika Sp.z o.o.), Bulgaria (Global MED LTD), Czech Republic (MTE spol. s.r.o.), Greece (Hemoglobe Hellas OE), Italy (BC Trade), Lithuania (UAB Abovita), Nordic Region (InfuTech Medical)Germany (Mediq), France (Medlife SAS), United Kingdom (Advanced Therapeutics (UK) Ltd.), Netherlands, Luxembourg, Belgium, Poland (Aero-Medika Sp.z o.o.), Bulgaria (Global MED LTD), Czech Republic (MTE spol. s.r.o.), Greece (Hemoglobe Hellas OE), Italy (BC Trade), Lithuania (UAB Abovita), Nordic Region (InfuTech Medical)
- USA (SOOIL LLC), Puerto Rico (G&T Diabetes Solutions)USA (SOOIL LLC), Puerto Rico (G&T Diabetes Solutions)
- New Zealand (Intuitive Therapeutics)New Zealand (Intuitive Therapeutics)
- Uruguay (BioCor Fenilop S.A.), Paraguay (Medsupar), Chile (Alatheia Medical S.A.)Uruguay (BioCor Fenilop S.A.), Paraguay (Medsupar), Chile (Alatheia Medical S.A.)
- Certifications/Patents
- US Food and Drug Administration (FDA) Approval: The company, as the world's first developer of insulin pumps, obtained FDA approval, gaining global recognition for its technology and quality.US Food and Drug Administration (FDA) Approval: The company, as the world's first developer of insulin pumps, obtained FDA approval, gaining global recognition for its technology and quality.
- European CE Mark Acquisition: Acquired the European CE certification, proving product competitiveness and safety in the European market.European CE Mark Acquisition: Acquired the European CE certification, proving product competitiveness and safety in the European market.
- ISO9001 and ISO13485 Quality Standard Certifications: Obtained international standard certifications for medical device manufacturing and quality management systems, ensuring product reliability.ISO9001 and ISO13485 Quality Standard Certifications: Obtained international standard certifications for medical device manufacturing and quality management systems, ensuring product reliability.
- GMP (Good Manufacturing Practice) Certification: Received recognition for conformity with domestic medical device manufacturing and quality control standards.GMP (Good Manufacturing Practice) Certification: Received recognition for conformity with domestic medical device manufacturing and quality control standards.
- German Federal Office for Information Security (BSI) Cyber Security Certification (Green Certificate): Achieved a favorable (green) rating in the German communication security test for the DANA Diabecare RS insulin pump, acknowledging the safety of its smart healthcare technology.German Federal Office for Information Security (BSI) Cyber Security Certification (Green Certificate): Achieved a favorable (green) rating in the German communication security test for the DANA Diabecare RS insulin pump, acknowledging the safety of its smart healthcare technology.
- Korea Internet & Security Agency (KISA) IoT Security Certification: Obtained domestic IoT security certification, enhancing the security reliability of smartphone-linked products.Korea Internet & Security Agency (KISA) IoT Security Certification: Obtained domestic IoT security certification, enhancing the security reliability of smartphone-linked products.
- Selected for the Ministry of Health and Welfare's 'Advanced Medical Technique Development Plan (G-7 Project)' (1995): Recognized for its innovative technology development capabilities by being selected for Korea's G-7 Project.Selected for the Ministry of Health and Welfare's 'Advanced Medical Technique Development Plan (G-7 Project)' (1995): Recognized for its innovative technology development capabilities by being selected for Korea's G-7 Project.
- Awarded '7 Million Dollar Export Tower' (2022): Received the '7 Million Dollar Export Tower' award at the 59th Trade Day ceremony, demonstrating its achievements in the global market.Awarded '7 Million Dollar Export Tower' (2022): Received the '7 Million Dollar Export Tower' award at the 59th Trade Day ceremony, demonstrating its achievements in the global market.
- Minister of Health and Welfare Award: Awarded the Minister of Health and Welfare Award in recognition of its outstanding contributions to diabetes treatment.Minister of Health and Welfare Award: Awarded the Minister of Health and Welfare Award in recognition of its outstanding contributions to diabetes treatment.
- Selected as a Global Hidden Champion: Designated as a 'Global Hidden Champion' by the Small and Medium Business Administration, receiving support for fostering it as an export-leading company.Selected as a Global Hidden Champion: Designated as a 'Global Hidden Champion' by the Small and Medium Business Administration, receiving support for fostering it as an export-leading company.
- Selected as a Global IP Star Company, Innobiz (Technology Innovation Small and Medium Business), and World Class Product: Received recognition for its innovative technology and growth potential from various government and institutional bodies.Selected as a Global IP Star Company, Innobiz (Technology Innovation Small and Medium Business), and World Class Product: Received recognition for its innovative technology and growth potential from various government and institutional bodies.
- Awarded '2018 Korea Global Power Brand Award': Received the award for its 'DANA Insulin Pump,' recognized as a groundbreaking product for diabetes patients.Awarded '2018 Korea Global Power Brand Award': Received the award for its 'DANA Insulin Pump,' recognized as a groundbreaking product for diabetes patients.
- Selected as a '2019 Hi-Seoul Brand Company': Designated as a 'Hi-Seoul Brand' company, a joint brand conferred by the Seoul Metropolitan Government and the Seoul Business Agency (SBA) to excellent small and medium-sized enterprises.Selected as a '2019 Hi-Seoul Brand Company': Designated as a 'Hi-Seoul Brand' company, a joint brand conferred by the Seoul Metropolitan Government and the Seoul Business Agency (SBA) to excellent small and medium-sized enterprises.
- Patents in Insulin Pump Related Technology: Holds worldwide patents for insulin pump-related technology, having successfully developed and commercialized the world's first miniature insulin pump.Patents in Insulin Pump Related Technology: Holds worldwide patents for insulin pump-related technology, having successfully developed and commercialized the world's first miniature insulin pump.
Introduction
Location
62 Yonggu-daero 2325beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
